Qilu Pharmaceutical Co., Ltd.
-
Founded in:
1992-08-21 -
Country:
China -
Address:
No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province -
Tax NO.:
91370000614073351Q -
Registered Funds:
600 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Risperidone |
Risperidone is a selective monoamine antagonist with high affinity for 5HT2 receptors, D2 receptors, α1 and α2 receptors, and H1 receptors. Its effect in treating schizophrenia is believed to be the result of a combined effect of antagonism on D2 receptors and 5HT2 receptors.
More
Risperidone is a selective monoamine antagonist with high affinity for 5HT2 receptors, D2 receptors, α1 and α2 receptors, and H1 receptors. Its effect in treating schizophrenia is believed to be the result of a combined effect of antagonism on D2 receptors and 5HT2 receptors. |
106266-06-2 | 54 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tadalafil |
By inhibiting phosphodiesterase 5 (PDE5), it increases the concentration of cyclic guanosine monophosphate (cGMP) and enhances erectile function. Sexual stimulation is required to stimulate the local release of nitric oxide (NO) to produce the effect. Tadalafil's selective inhibition of PDE5 is several to tens of thousands times stronger than other phosphodiesterases, and it may also affect the concentration of cGMP in the prostate, bladder smooth muscle and blood vessels, thereby alleviating BPH symptoms.
More
By inhibiting phosphodiesterase 5 (PDE5), it increases the concentration of cyclic guanosine monophosphate (cGMP) and enhances erectile function. Sexual stimulation is required to stimulate the local release of nitric oxide (NO) to produce the effect. Tadalafil's selective inhibition of PDE5 is several to tens of thousands times stronger than other phosphodiesterases, and it may also affect the concentration of cGMP in the prostate, bladder smooth muscle and blood vessels, thereby alleviating BPH symptoms. |
171596-29-5 | 103 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tadalafil |
It is not possible to directly extract specific pharmacological descriptions from the above information.
More
It is not possible to directly extract specific pharmacological descriptions from the above information. |
171596-29-5 | 103 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Trifluridine |
Thymine nucleotide analogs, after being taken up into cancer cells, can be incorporated into DNA, interfering with DNA synthesis and inhibiting cell proliferation.
More
Thymine nucleotide analogs, after being taken up into cancer cells, can be incorporated into DNA, interfering with DNA synthesis and inhibiting cell proliferation. |
70-00-8 | 21 | |
| Tipiracil hydrochloride |
Thymidine phosphorylase inhibitors increase trifluridine exposure by inhibiting the enzyme thymidine phosphorylase, which is involved in the metabolism of trifluridine.
More
Thymidine phosphorylase inhibitors increase trifluridine exposure by inhibiting the enzyme thymidine phosphorylase, which is involved in the metabolism of trifluridine. |
183204-72-0 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Palonosetron Hydrochloride |
Extract from the above information
More
Extract from the above information |
135729-62-3 | 34 |